OBINNA KENNETH DIDIGWU

Mr. OBINNA KENNETH DIDIGWU

Pharmaceutical and medicinal chemistry, University o Nigeria, Nsukka, Nsukka, Enugu, Nigeria
orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2023 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
IEIkenna Franklin Ezema
Ikenna Franklin Ezema
VAVictor Akwu
Victor Akwu
ODOBINNA KENNETH DIDIGWU
OBINNA KENNETH DIDIGWU
JOJude Ogbonna
Jude Ogbonna
AUAugustine Chidera Ugwu
Augustine Chidera Ugwu
Charles O. NnadiCharles O. Nnadi
Charles O. Nnadi
The genome sequence of Leishmania has given rise to diverse novel drug targets, and their identification remains the first step in drug discovery. This study aims to identify the possible anti-leishmanicidal activity target(s) of N1, N4-[dibenzylbutane-4′,4″-(dioxymethylenebenzene)]-1,4-diamine from a plethora of pathways in kinetoplastids. The compound was docked using AutoDockTools-1.5.6 against eight co-crystallized proteins selected from the protein data bank, each representing important biosynthetic pathways. The evaluation of the best conformational protein–ligand poses showed that the N, N′-substituted diamine binds more efficiently to glyceraldehyde-3-phosphate dehydrogenase (G3PDH) (E = −8.97 Kcal/mol and Ki = 0.267 µM; Ki co-crystallized ligand = 19.39 µM), which is responsible for the conversion of glyceraldehyde-3-phosphate to 1,3-bisphosphoglycerate and pteridine reductase I (PTR1) (E = −8.75 Kcal/mol and Ki = 0.387 µM; Ki co-crystallized ligand = 60.56 µM), which reduces both pterins and folates to tetrahydrobiopterin and tetrahydrofolate, respectively. Moderate binding activity by the ligand was observed for the protein kinases (CDKs) (E = −8.37 Kcal/mol and Ki = 0.729 µM; Ki co-crystallized ligand = 26.80 µM) and trypanothione reductase (TR) (E = −8.57 Kcal/mol and Ki = 0.525 µM; Ki co-crystallized ligand = 174.68 µM) of the trypanothione biosynthetic pathway. With E > −7.35 Kcal/mol and Ki > 4.10 µM, the ligand appears to have no significant inhibition of the squalene synthase (SQS), lactoyl glutathione lyase (LGL) or the pteridine synthase (TS) of the sterol, glyoxalase and trypanothione biosynthetic pathways. The efficient inhibition of G3PDH and PTR1 targets in Leishmania by N, N′-substituted diamine molecule provides more insights into understanding the mechanism of leishmanicidal activity.

3 April 2024 in Proceedings
Verified
Conference Paper
Open access
PDF file
ODOBINNA KENNETH DIDIGWU
OBINNA KENNETH DIDIGWU
Charles O. NnadiCharles O. Nnadi
Charles O. Nnadi
Terpenoids constitute one of the most widespread phytoconstituents, with complex chemical structures, a plurality of biological activities, and variable pharmacokinetic profiles. The emerging roles of terpenoids in drug design require an understanding of their ADME/T properties for structure modification and possible repurposing. This study evaluated the drug-likeness of phytotoxic terpenoids obtained from the Toxic Plants–Phytotoxins (TPPT) database via in silico prediction of their pharmacokinetic and toxicity profiles. The TPPT database, comprising 1586 phytotoxins, was filtered to 576 terpenoids. Using Swiss ADME, pkCSM, and ProTox II webserver tools, Lipinski’s properties and topological polar surface area (TPSA) were predicted for drug-likeness, alongside their pharmacokinetic profiles and toxicity on various organ endpoints. In total, 9.55% of the terpenoids obeyed Lipinski’s rule of five. None of the compounds inhibited hERG I, while 12.73% inhibited hERG II, implying that some were cardiotoxic. In addition, 25.45% of the compounds elicited AMES toxicity; 25.45% caused liver injury; and 32.73% caused skin sensitivity. Furthermore, 72.73% showed high Caco-2 permeability and 76.36% displayed good skin permeability, implying their suitability for transdermal drug delivery. P-glycoprotein was extruded by 29.09% of the compounds and inhibited by 34.45%; 47.27% of the compounds readily crossed the blood–brain barrier, 23.64% penetrated the central nervous system, 56.36% were sensitive to cytochrome p450 isoenzymes, 36.37% inhibited cytochrome p450 isoenzymes, 49.09% resulted in immunotoxicity, 1.82% were toxic to cells, 14.55% would cause cancer, and 21.82% showed high tolerated doses in humans. Most of them showed a high volume of distribution, were free-flowing in plasma, and demonstrated moderate bioavailability, while all had high intestinal absorption and 78.18% demonstrated good water solubility. This study identified marrubiin as a drug-like, non-toxic, and highly bioavailable terpenoid with strong potential for further optimization, and development.

27 March 2024 in Proceedings
Verified
Conference Paper
Open access
PDF file
Charles O. NnadiCharles O. Nnadi
Charles O. Nnadi
SBSimnom Hope Banda
Simnom Hope Banda
MUMichael Uchechukwu Uzonwanne
Michael Uchechukwu Uzonwanne
ODOBINNA KENNETH DIDIGWU
OBINNA KENNETH DIDIGWU
Targeting cancer stem cells (CSCs) in anticancer discovery is very difficult due to the resistance of CSCs to conventional drugs, their low proliferation rate, improved DNA damage repair, and the overexpression of anti-apoptotic proteins and multidrug resistance transporters. Different CSC targets, such as the ABC cassette, surface markers, signal cascade, and tumour microenvironment, are involved in the interruption of cell signaling pathways that are critical for the survival and functioning of the CSC population. The study aims to identify potential drug-like phytotoxic alkaloids with anticancer activity from the toxic plants-phytotoxins (TPPTs) database. A total of 1586 phytotoxins were filtered to obtain 653 alkaloids. Lipinski’s properties and the TPSA of alkaloids were predicted for drug likeness and toxicity based on various organ endpoints. Compounds that obeyed Lipinski’s rule of five, with moderate or no toxicity and an LD50 of >2000 mg/kg, were selected. The 12 drug-like phytotoxic alkaloids obtained from the filtering were docked on an isomerase-perdeuterated E65Q-TIM protein (ID: 7AZA; resolution = 1.10 Å) cocrystallized with phosphoglycolohydroxamate. The best binding poses were ranked using their binding energies (E) and inhibition constants (Ki). An evaluation of the protein—ligand’s best conformational poses allowed us to identify three alkaloids (norcoclaurine, palustridiene, and apovincamine) with Ki 1.00 µM and E −9.00 kcal/mol. All the docked ligands could bind more efficiently to the isomerase-perdeuterated E65Q-TIM protein than the co-crystallized phosphoglycolohydroxamate. Significant protein—ligand binding interactions also occurred for (-)-eburnamonine (E = −8.03 kcal/mol; Ki = 1.30 µM) and retamine (E = −7.81 kcal/mol; Ki = 1.89 µM). The efficient inhibition of perdeuterated E65Q-TIM in CSCs using phytotoxic alkaloids provided more insights into understanding the mechanisms of the anticancer activity of phytotoxic alkaloids.

12 April 2024 in Proceedings
Verified
Conference Paper
Open access
PDF file
ODOBINNA KENNETH DIDIGWU
OBINNA KENNETH DIDIGWU
EKEmmanuel Amuchechukwu Kevin
Emmanuel Amuchechukwu Kevin
MEMichael Osita Edeh
Michael Osita Edeh
SOSunday Okafor
Sunday Okafor
Pyrrolizidine alkaloids (PAs) are heterocyclic organic compounds of natural origin synthesized by either plants or microorganisms